Official 2024 U.S. DOL Form 5500 summary for Leading Pharma, LLC (Leading Pharma 401(k) Plan · EIN 47-1297885 · PN 001): $5.95M net assets, 182 active participants, and $70.07 per $10,000 (70.07 bps).
| Plan Sponsor | Leading Pharma, LLC |
|---|---|
| Filing Identifier | Leading Pharma 401(k) Plan · EIN 47-1297885 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (NJ) |
| Asset-Size Peer Cohort | $5M-$25M |
| Plan Net Assets (2024) | $5.95M |
| Active Participants | 182 |
| Direct Admin Fee Rate | $70.07 per $10,000 (70.07 bps) |
| Cohort Peer Median | $37.06 per $10,000 (37.06 bps) |
| Primary Recordkeeper / Provider | Commonwealth Financial Network |
| Schedule H Line 4a Remittance | Timely Employer Remittance (0 reported on Line 4a) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI